Please Wait...

IL-1β // Interleukin 1 beta

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Interleukin 1β (IL-1β) belongs to the IL-1 family. In this family IL-1α and IL-1β bind to the same receptor and have identical biological activity. IL-1β is secreted, circulate in the bloodstream, and have a systemic activity, when IL-1α is generally associated with the producing cells plasma membrane and acts more locally (Sims and Smith, 2010). Active Il-1β is produced by cleavage ofpro-IL-1β by caspase-1 or neutrophil protease. IL-1β is secreted by innate immune cells and is a pro-inflammatory cytokine highly produced in several inflammatory diseases such as familial Mediterranean fever, Pyogenic arthritis pyoderma gangaenosum and acne, crystal‑induced arthropathies, rheumatoid arthritis and osteoarthritis (Schett et al., 2015).

Bioclinica Lab employs a high sensitive manual sandwich immunoassay for measurement of IL-1β in serum.


Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Still time to catch up on summer reading on recent developments in #Alzheimer's Disease Fluid Biomarkers here int t…
bioclinica (Yesterday)
Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain…
bioclinica (2 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai…
bioclinica (4 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (1 week ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining…
bioclinica (1 week ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen